MAGNESIUM METABOLISM AND CLINICAL CHARACTERISTICS OF PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE
https://doi.org/10.20996/1819-6446-2010-6-4-461-468
Abstract
Aim. To study relationship of the clinical state and cardiac functional parameters with magnesium metabolism indices in patients with chronic ischemic heart disease (IHD).
Material and methods. Patients with stable angina pectoris, II-III class (n=480) were involved into the study. Evaluation of the following items was performed: disease course, anxiodepressive syndrome intensity, exercise tolerance, blood and urine electrolyte profile, systolic and diastolic left ventricle function, endothelium-dependent and endotheliumnondependent vasodilatation, i/v magnesium load test, Holter electrocardiogram monitoring.
Results. High prevalence of systemic magnesium deficiency (17.9 and 37.5% according to serum and erythrocyte levels, respectively) was found in IHD patients. Severity of magnesium deficiency in IHD patients depended on duration of disease, experience of myocardial infarction, myocardial ischemia seriousness, disorders of endothelium vasodilating function and left ventricle diastolic function, severity of concomitant anxiety. Exercise tests were changed in IHD patients with magnesium deficiency.
Conclusion. The study data let to consider that magnesium deficiency involves into the IHD pathogenesis.
About the Authors
A. V. Yezhov
Izhevsk State Medical Academy
Russian Federation
Kommunarov ul. 281, Izhevsk, 426034
Russian Federation
Kommunarov ul. 281, Izhevsk, 426034
L. T. Pimenov
Izhevsk State Medical Academy
Russian Federation
Kommunarov ul. 281, Izhevsk, 426034
Russian Federation
Kommunarov ul. 281, Izhevsk, 426034
M. A. Makarova
Medical and sanitary hospital №3
Russian Federation
Promyshlennaya ul. 52, Izhevsk, 426063
Russian Federation
Promyshlennaya ul. 52, Izhevsk, 426063
T. V. Savelyev
Izhevsk State Medical Academy
Russian Federation
Kommunarov ul. 281, Izhevsk, 426034
Russian Federation
Kommunarov ul. 281, Izhevsk, 426034
References
1. Громова О.А. Магний и пиридоксин: основы знаний. М.: ПротоТип; 2006.
2. Sontia B., Touyz R.M. Role of magnesium in hypertension. Arch Biochem Biophys 2007; 458(1): 33–9.
3. Кудрин А.В., Громова О.А. Микроэлементы в неврологии. М.: ГЭОТАР-Медиа, 2006.
4. Изможерова Н.В., Попов А.А., Фоминых М.И. и др. Дефицит магния в климактерическом периоде. Клиническая медицина 2007; 85(5): 62-64.
5. Bhudia S.K., Cosgrove D.M., Naugle R.I. et al. Magnesium as a neuroprotectant in cardiac surgery: a randomized clinical trial. J Thorac Cardiovasc Surg 2006; 131 (4): 853-61.
6. Ma B., Lawson A.B., et al. Dairy, magnesium, and calcium intake in relation to insulin sensitivity: approaches to modeling a dose-dependent association. Am J Epidemiol 2006; 164 (5): 449-58.
7. Hoshino K., Ogawa K., Hishitani T. et al. Successful uses of magnesium sulfate for torsades de pointes in children with long QT syndrome. Pediatr Int 2006; 48 (2): 112–7.
8. He K. Magnesium intake and incidence of metabolic syndrome among young adults. Circulation 2006; 113: 1675-82.
9. Witte K.K., Clark A.L. Micronutrients and their supplementation in chronic cardiac failure. An update beyond theoretical perspectives. Heart Fail Rev 2006;11(1): 65-74.
10. Кишкун А.А. Руководство по лабораторным методам диагностики. М.: ГЭОТАР-Медиа; 2007.
11. Тиц Н.У. Энциклопедия клинических лабораторных тестов. М.: Лабинформ; 1997.
12. Rasmussen H.S., McNair P., Gøransson L. et al. Magnesium deficiency in patients with ischemic heart disease with and without acute myocardial infarction uncovered by an intravenous loading test. Arch Intern Med 1988;148(2):329-32.
Review
For citations:
Yezhov A.V., Pimenov L.T., Makarova M.A., Savelyev T.V. MAGNESIUM METABOLISM AND CLINICAL CHARACTERISTICS OF PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE. Rational Pharmacotherapy in Cardiology. 2010;6(4):461-468. (In Russ.) https://doi.org/10.20996/1819-6446-2010-6-4-461-468
Views:
658
Email this article 